CUSIP: 45409B412
Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / IQ S&P HGH YLD
-
Total 13F shares
-
752,141
-
Share change
-
-2,665,078
-
Total reported value
-
$18,997,000
-
Price per share
-
$25.26
-
Number of holders
-
24
-
Value change
-
-$66,552,725
-
Number of buys
-
10
-
Number of sells
-
18
Quarterly Holders Quick Answers
What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2021
-
Previous quarter:
Q1 2021
Recent filing periods for CUSIP 45409B412:
Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q2 2021
As of 30 Jun 2021,
INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
752,141 shares.
The largest 10 holders included
MORGAN STANLEY, CITADEL ADVISORS LLC, GeoWealth Management, LLC, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, TAP Consulting, LLC, Wagner Wealth Management, LLC, ENVESTNET ASSET MANAGEMENT INC, OSAIC HOLDINGS, INC., and Lake Point Wealth Management.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.